N Axicabtagene ciloleucel 10, Lisocabtagene Tender - 145986801

Procurement Summary

Country: Japan

Summary: N Axicabtagene ciloleucel 10, Lisocabtagene maraleucel 10

Deadline: 16 Sep 2026

Posting Date: 27 Jul 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 145986801

Document Ref. No.:

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

33652100 - Antineoplastic agents
33615100 - Insulin
24612300 - Nitro-glycerine

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

N Axicabtagene ciloleucel 10, Lisocabtagene maraleucel 10
Classification: 0004 Medical & Pharmaceutical Products

Summay of Notice: ⑴ Official in charge of disbursement of the procuring entity : Shingo Yoshii, The Obligating Officer for Contractual Affairs Delegate Head, Finance and Facilities Department University of Toyama

⑵ Classification of the products to be procured : 4

⑶ Nature and quantity of the products to be purchased :

N Axicabtagene ciloleucel 10

O Lisocabtagene maraleucel 10

⑷ Delivery period : From 1 October, 2026 through 30 June, 2027

⑸ Delivery place : The places specified by the Obligating Officer for Contractual Affairs Delegate Head

⑹ Qualifications for participating in the tendering procedures : Suppliers eligible for participating in the proposed tender are those who shall :

A not come under Article 5 and 6 of the Regulation concerning the Contract for University of Toyama Furthermore, minors, Person under Conservatorship or Person under Assistance that obtained the consent necessary for concluding a contract may be applicable under cases of special reasons within the said clause,

B have the Grade A, Grade B or Grade C qualification during fiscal 2026 in the Tokai・Hokuriku area in sales of product for participating in tenders by Single qualification for every ministry and agency,

C prove to have obtained the first-class license for selling drugs in accordance with the Law on Securing Quality, Efficacy and Safety of Products including Pharmaceuticals and Medical Devices,

D meet the qualification requirements which The Obligating Officer Director-General may specify in accordance with Article 8 of the Regulation,

E not be currently under a suspension of business order as instructed by The Obligating Officer Director-General.

⑺ Time limit of tender : 17 : 00 16 September, 2026

⑻ Contact point for the notice : Ayumi Takamura, Accounting Division II Finance and Facilities Department University of Toyama, 2630 Sugitani Toyama-shi 930-...

Documents

 Tender Notice